Detalles de la búsqueda
1.
Effectiveness of 2 and 3 mRNA COVID-19 Vaccines Doses against Omicron and Delta-Related Outpatient Illness among Adults, October 2021 - February 2022
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22273535
2.
mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged >=16 Years in the United States, February to May 2021
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21260647
3.
Neutralizing Antibody to Omicron BA.1, BA.2 and BA.5 in COVID-19 Patients
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22278552
4.
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259776
5.
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22276228
6.
Association between COVID-19 mRNA vaccination and COVID-19 illness and severity during Omicron BA.4 and BA.5 sublineage periods
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22280459
7.
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-469906
8.
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270558
Resultados
1 -
8
de 8
1
Próxima >
>>